APA (7th ed.) Citation

Zuckermann, M., He, C., Andrews, J., Bagchi, A., Sloan-Henry, R., Bianski, B., . . . Zhang, J. (2024). Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy. Molecular Cancer, 23(1), 1. https://doi.org/10.1186/s12943-024-02027-6

Chicago Style (17th ed.) Citation

Zuckermann, Marc, et al. "Capmatinib Is an Effective Treatment for MET-fusion Driven Pediatric High-grade Glioma and Synergizes with Radiotherapy." Molecular Cancer 23, no. 1 (2024): 1. https://doi.org/10.1186/s12943-024-02027-6.

MLA (9th ed.) Citation

Zuckermann, Marc, et al. "Capmatinib Is an Effective Treatment for MET-fusion Driven Pediatric High-grade Glioma and Synergizes with Radiotherapy." Molecular Cancer, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12943-024-02027-6.